How hospice became big business. A new investigation in The New Yorker reveals an industry that at times puts profits before patients.
U.S. drug manufacturers import at least 80% of their active pharmaceutical ingredients with an every increasing share coming from China and India. We’ll discuss some of the new questions being raised about safety standards of these imports.
- Marc Kaufman Reporter on the national desk of "The Washington Post"
- Dr. Gilbert Ross Medical/Executive Director American Council on Science and Health
- Caroline Loew SVP, Scientific and Regulatory Affairs, PhRMA
- Dr. Sidney Wolfe Director of the Health Research Group at Public Citizen; editor of WorstPills.org
- Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee
Most Recent Shows
Pulitzer Prize-winning biographer Jon Meacham on the evolution of Abraham Lincoln's moral principles and political leadership -- and what the era of Lincoln can teach us about the state of our democracy today.
What troubles at Twitter say about the state of social media -- and why one tech watcher argues this could transform the industry in positive ways.
Political analyst Norman Ornstein on control of Congress, the red wave that wasn't, and other lessons from the midterm elections.